ProfileGDS5822 / ILMN_3158909
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 95% 96% 96% 95% 97% 96% 96% 96% 97% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 11310.995
GSM1276600PDAC Late Ablation Control 21528.496
GSM1276601PDAC Late Ablation Control 31591.396
GSM1276602PDAC Late Ablation 11133.895
GSM1276603PDAC Late Ablation 2179097
GSM1276604PDAC Late Ablation 31566.196
GSM1303940PDAC Late Ablation_anti-CTLA4 11417.796
GSM1303941PDAC Late Ablation_anti-CTLA4 21524.896
GSM1303942PDAC Late Ablation_anti-CTLA4 32103.197